Skip to main content
Clinical Trials/JPRN-UMIN000017582
JPRN-UMIN000017582Completed未知

The effect of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head - The effect of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head

Department of Orthopaedic Surgery, Hokkaido University Graduate School of Medicine0 sites100 target enrollmentStarted: May 15, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
19years-old to 70years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • We excluded 1) Patients who had been followed for less than 6 months 2) The administration periods were not identified 3) Stage 3B or 4 in the Japansese Investigation Committee staging system 4) Type A or B in the Japansese Investigation Committee classification system

Investigators

Sponsor
Department of Orthopaedic Surgery, Hokkaido University Graduate School of Medicine

Similar Trials

Completed
Not Applicable
Evaluation of the efficacy of teriparatide for distal radial fracture repair after plate fixation in osteoporotic patients:A prospective randomized control study.osteoporosis
JPRN-UMIN000015903Yokohama City University Medical Center20
Active, not recruiting
Phase 1
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip FracturePostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 17.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2008-002693-35-DKEli Lilly and Company Ltd220
Active, not recruiting
Phase 1
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip Fracture
EUCTR2008-002693-35-GBEli Lilly and Company Ltd171
Active, not recruiting
Phase 1
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip Fracture - GHDKPostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 9.1Level: LLTClassification code 10031282Term: Osteoporosis
EUCTR2008-002693-35-NOEli Lilly and Company Ltd171
Active, not recruiting
Not Applicable
Comparison of Teriparatide with Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip FracturePostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 14.1Level: LLTClassification code 10031288Term: Osteoporosis with fractureSystem Organ Class: 100000004859
EUCTR2008-002693-35-ATEli Lilly and Company Ltd